Loss of Nexilin function leads to a recessive lethal fetal cardiomyopathy characterized by cardiomegaly and endocardial fibroelastosis.
NEXN
Nexilin
cardiomyopathy
lethal
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
30
12
2021
received:
06
10
2021
accepted:
22
01
2022
pubmed:
16
2
2022
medline:
18
5
2022
entrez:
15
2
2022
Statut:
ppublish
Résumé
The Nexilin F-Actin Binding Protein (Nexilin) encoded by NEXN is a cardiac Z-disc protein important for cardiac function and development in humans, zebrafish, and mice. Heterozygote variants in the human NEXN gene have been reported to cause dilated and hypertrophic cardiomyopathy. Homozygous variants in NEXN cause a lethal form of human fetal cardiomyopathy, only described in two patients before. In a Swedish, four-generation, non-consanguineous family comprising 42 individuals, one female had three consecutive pregnancies with intrauterine fetal deaths caused by a lethal form of dilated cardiomyopathy. Whole-exome sequencing and variant analysis revealed that the affected fetuses were homozygous for a NEXN variant (NM_144573:c.1302del;p.(Ile435Serfs*3)). Moreover, autopsy and histology staining declared that they presented with cardiomegaly and endocardial fibroelastosis. Immunohistochemistry staining for Nexilin in the affected fetuses revealed reduced antibody staining and loss of striation in the heart, supporting loss of Nexilin function. Clinical examination of seven heterozygote carriers confirmed dilated cardiomyopathy (two individuals), other cardiac findings (three individuals), or no cardiac deviations (two individuals), indicating incomplete penetrance or age-dependent expression of dilated cardiomyopathy. RNA sequencing spanning the variant in cDNA blood of heterozygote individuals revealed nonsense-mediated mRNA decay of the mutated transcripts. In the current study, we present the first natural course of the recessively inherited lethal form of human fetal cardiomyopathy caused by loss of Nexilin function. The affected family had uneventful pregnancies until week 23-24, followed by fetal death at week 24-30, characterized by cardiomegaly and endocardial fibroelastosis.
Identifiants
pubmed: 35166435
doi: 10.1002/ajmg.a.62685
pmc: PMC9306924
doi:
Substances chimiques
Microfilament Proteins
0
NEXN protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1676-1687Informations de copyright
© 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
Références
PLoS One. 2017 Dec 18;12(12):e0189489
pubmed: 29253866
Circulation. 2006 Apr 11;113(14):1807-16
pubmed: 16567565
Circulation. 2019 Jul 2;140(1):55-66
pubmed: 30982350
Nucleic Acids Res. 2021 Jan 8;49(D1):D884-D891
pubmed: 33137190
Biochem Biophys Res Commun. 2005 May 20;330(4):1127-31
pubmed: 15823560
Nat Med. 2009 Nov;15(11):1281-8
pubmed: 19881492
PLoS One. 2013;8(1):e55634
pubmed: 23383252
Curr Cardiol Rep. 2013 Jul;15(7):375
pubmed: 23686784
J Cell Biol. 1998 Nov 30;143(5):1227-38
pubmed: 9832551
J Inherit Metab Dis. 1996;19(3):373-4
pubmed: 8803786
PLoS One. 2013 Dec 11;8(12):e82135
pubmed: 24349201
Circulation. 2018 Nov 20;138(21):2359-2366
pubmed: 30021846
Sci Rep. 2020 Feb 10;10(1):2226
pubmed: 32041989
Cardiol Young. 2019 Oct;29(10):1257-1263
pubmed: 31477192
Circ Heart Fail. 2020 Jul;13(7):e006935
pubmed: 32635769
Nat Genet. 2002 Jul;31(3):241-7
pubmed: 12053178
J Am Coll Cardiol. 2019 Sep 17;74(11):1480-1490
pubmed: 31514951
Int J Legal Med. 2019 Nov;133(6):1699-1709
pubmed: 31392414
Circ Heart Fail. 2018 Nov;11(11):e005220
pubmed: 30571196
J Card Fail. 2009 Mar;15(2):83-97
pubmed: 19254666
Eur J Hum Genet. 2021 May;29(5):808-815
pubmed: 33547425
Circ Res. 2017 Sep 15;121(7):731-748
pubmed: 28912180
Cardiovasc Pathol. 2013 Sep-Oct;22(5):345-50
pubmed: 23518027
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Nat Rev Cardiol. 2013 Sep;10(9):531-47
pubmed: 23900355
Eur Heart J. 2008 Jan;29(2):270-6
pubmed: 17916581
Circulation. 1989 Sep;80(3):564-72
pubmed: 2766509
Nat Rev Cardiol. 2021 Jan;18(1):22-36
pubmed: 32895535
Hum Mutat. 2019 Aug;40(8):1030-1038
pubmed: 31116477
Obstet Gynecol. 2001 Nov;98(5 Pt 2):925-7
pubmed: 11704206
Mol Cell Probes. 2015 Oct;29(5):308-14
pubmed: 25979592
Ann Intern Med. 2005 Jul 19;143(2):108-15
pubmed: 16027452
Sci Rep. 2018 Aug 29;8(1):13025
pubmed: 30158653
Nature. 2010 Oct 28;467(7319):1099-103
pubmed: 20981099
Am J Hum Genet. 2010 Nov 12;87(5):687-93
pubmed: 20970104
Am J Med Genet A. 2022 Jun;188(6):1676-1687
pubmed: 35166435
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Clin Genet. 2019 Mar;95(3):356-367
pubmed: 30471092
Eur J Med Genet. 2020 May;63(5):103875
pubmed: 32058062
Cardiovasc Res. 2014 Jul 15;103(2):228-37
pubmed: 24866383
Am J Med Genet. 2001 Jul 1;101(3):255-8
pubmed: 11424141
J Am Coll Cardiol. 1998 Jan;31(1):195-201
pubmed: 9426040
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Am J Med Genet A. 2021 Aug;185(8):2464-2470
pubmed: 33949776
Eur Heart J. 2016 Jun 14;37(23):1850-8
pubmed: 26792875
Basic Res Cardiol. 2016 Jan;111(1):6
pubmed: 26659360
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Sci Rep. 2016 Oct 07;6:34234
pubmed: 27713484
Database (Oxford). 2014 Oct 03;2014:
pubmed: 25281234